MBX Biosciences, Inc. Common Stock
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
87.00 |
231.70 |
| Przychód Δ r/r |
0.00% |
0.00% |
0.00% |
0.00% |
inf% |
166.32% |
| Przychód (min) |
0.00 |
0.00 |
0.00 |
0.00 |
87.00 |
231.70 |
| Przychód (max) |
0.00 |
0.00 |
0.00 |
0.00 |
87.00 |
231.70 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-486.68 |
-93.47 |
-96.31 |
-108.32 |
-85.71 |
-17.03 |
| Zysk netto % |
-inf% |
-inf% |
-inf% |
-inf% |
-98.51% |
-7.35% |
| EPS (średnia) |
-11.52 |
-2.80 |
-2.90 |
-3.53 |
-2.57 |
-0.51 |
| Liczba analityków (Przychody) |
0 |
0 |
0 |
0 |
1 |
2 |
| Liczba analityków (EPS) |
3 |
3 |
4 |
5 |
2 |
1 |
| symbol |
MBX |
MBX |
MBX |
MBX |
MBX |
MBX |